Interaction of the plasmid-encoded quinolone resistance protein QnrB19 with Salmonella Typhimurium DNA gyrase.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 06 04 2020
revised: 18 05 2020
accepted: 03 06 2020
pubmed: 17 7 2020
medline: 25 6 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

Plasmid-encoded quinolone resistance protein Qnr is an important factor in bacterial resistance to quinolones. Qnr interacts with DNA gyrase and reduces susceptibility to quinolones. The gene qnr likely spreads rapidly among Enterobacteriaceae via horizontal gene transfer. Though the vast amounts of epidemiological data are available, molecular details of the contribution of QnrB19, the predominant Qnr in Salmonella spp., to the acquisition of quinolone resistance has not yet been understood well. We aimed to examine the role of QnrB19 in quinolone resistance acquisition using recombinant Salmonella Typhimurium DNA gyrases and QnrB19. Recombinant QnrB19 was expressed in E. coli and purified by Ni-NTA agarose column chromatography. DNA supercoiling activities of recombinant Salmonella Typhimurium DNA gyrase were assessed with or without QnrB19 under the existence of three quinolones to measure IC The IC QnrB19 was shown for the first time in vitro to have ability to grant non-classical quinolone resistance to S. Typhimurium DNA gyrase. Structural insight on quinolones in this study may contribute to investigate drugs useful for preventing the spread of plasmid carrying PMQR along with other factors associating with antimicrobial resistance in S. Typhimurium and other bacteria.

Sections du résumé

BACKGROUND BACKGROUND
Plasmid-encoded quinolone resistance protein Qnr is an important factor in bacterial resistance to quinolones. Qnr interacts with DNA gyrase and reduces susceptibility to quinolones. The gene qnr likely spreads rapidly among Enterobacteriaceae via horizontal gene transfer. Though the vast amounts of epidemiological data are available, molecular details of the contribution of QnrB19, the predominant Qnr in Salmonella spp., to the acquisition of quinolone resistance has not yet been understood well.
OBJECTIVE OBJECTIVE
We aimed to examine the role of QnrB19 in quinolone resistance acquisition using recombinant Salmonella Typhimurium DNA gyrases and QnrB19.
MATERIALS AND METHODS METHODS
Recombinant QnrB19 was expressed in E. coli and purified by Ni-NTA agarose column chromatography. DNA supercoiling activities of recombinant Salmonella Typhimurium DNA gyrase were assessed with or without QnrB19 under the existence of three quinolones to measure IC
RESULTS RESULTS
The IC
CONCLUSION CONCLUSIONS
QnrB19 was shown for the first time in vitro to have ability to grant non-classical quinolone resistance to S. Typhimurium DNA gyrase. Structural insight on quinolones in this study may contribute to investigate drugs useful for preventing the spread of plasmid carrying PMQR along with other factors associating with antimicrobial resistance in S. Typhimurium and other bacteria.

Identifiants

pubmed: 32669211
pii: S1341-321X(20)30188-4
doi: 10.1016/j.jiac.2020.06.002
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Quinolones 0
DNA Gyrase EC 5.99.1.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1139-1145

Informations de copyright

Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Ruttana Pachanon (R)

Division of Bioresources, Research Center for Zoonosis Control, Hokkaido University, Japan.

Kentaro Koide (K)

Division of Bioresources, Research Center for Zoonosis Control, Hokkaido University, Japan.

Siriporn Kongsoi (S)

Faculty of Veterinary Medicine, Kasetsart University, Thailand.

Chie Nakajima (C)

Division of Bioresources, Research Center for Zoonosis Control, Hokkaido University, Japan; Global Station for Zoonosis Control, Hokkaido University, Japan.

Thoko Flav Kapalamula (TF)

Division of Bioresources, Research Center for Zoonosis Control, Hokkaido University, Japan.

Orasa Suthienkul (O)

Center of Education and Research in EcoHealth and OneHealth, Faculty of Public Health, Thammasat University, Thailand; Center of Excellence in Global Health, Faculty of Public Health, Thammasat University, Thailand.

Yasuhiko Suzuki (Y)

Division of Bioresources, Research Center for Zoonosis Control, Hokkaido University, Japan; Global Station for Zoonosis Control, Hokkaido University, Japan. Electronic address: suzuki@czc.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH